日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

P2 purinergic receptor expression and function in tumor-related immune cells

肿瘤相关免疫细胞中P2嘌呤能受体的表达和功能

Manoharan, Vahinipriya; Adegbayi, Oluwafemi O; Maynard, Janielle P

P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer

P2X4嘌呤能受体是治疗侵袭性前列腺癌的潜在靶点

Maynard, Janielle P; Lu, Jiayun; Vidal, Igor; Hicks, Jessica; Mummert, Luke; Ali, Tamirat; Kempski, Ryan; Carter, Ayanna M; Sosa, Rebecca Y; Peiffer, Lauren B; Joshu, Corinne E; Lotan, Tamara L; De Marzo, Angelo M; Sfanos, Karen S

P2 purinergic receptor dysregulation in urologic disease

泌尿系统疾病中的P2嘌呤能受体失调

Maynard, Janielle P; Sfanos, Karen S

GSTP1 positive prostatic adenocarcinomas are more common in Black than White men in the United States.

在美国,GSTP1阳性前列腺腺癌在黑人男性中比在白人男性中更常见

Vidal Igor, Zheng Qizhi, Hicks Jessica L, Chen Jiayu, Platz Elizabeth A, Trock Bruce J, Kulac Ibrahim, Baena-Del Valle Javier A, Sfanos Karen S, Ernst Sarah, Jones Tracy, Maynard Janielle P, Glavaris Stephanie A, Nelson William G, Yegnasubramanian Srinivasan, De Marzo Angelo M

P2X3 purinergic receptor overexpression is associated with poor recurrence-free survival in hepatocellular carcinoma patients

P2X3嘌呤能受体过度表达与肝细胞癌患者较差的无复发生存期相关

Maynard, Janielle P; Lee, Ju-Seog; Sohn, Bo Hwa; Yu, Xiaoying; Lopez-Terrada, Dolores; Finegold, Milton J; Goss, John A; Thevananther, Sundararajah

P2Y2 purinergic receptor activation is essential for efficient hepatocyte proliferation in response to partial hepatectomy

P2Y2嘌呤能受体激活对于肝细胞在部分肝切除术后有效增殖至关重要。

Tackett, Bryan C; Sun, Hongdan; Mei, Yu; Maynard, Janielle P; Cheruvu, Sayuri; Mani, Arunmani; Hernandez-Garcia, Andres; Vigneswaran, Nadarajah; Karpen, Saul J; Thevananther, Sundararajah